Phenobarbital therapy has been shown to be effective in reducing plasma bilirubin levels in patients with Crigler-Najjar syndrome type 2. Administration of 60-180 mg/day of the drug (in divided doses) can reduce serum bilirubin levels by at least 25%. A response should be expected within 2-3 weeks.
Get more content like this and the inside gist on all the fun things that happen at Healthsoothe straight to your inbox when you Subscribe to the Healthsoothe newsletter. Do it now!